Towards a Better Crystal Ball: Urinary C-C Motif Chemokine Ligand 14 (CCL14) and Persistent Severe AKI
- PMID: 35919534
- PMCID: PMC9337887
- DOI: 10.34067/KID.0002162022
Towards a Better Crystal Ball: Urinary C-C Motif Chemokine Ligand 14 (CCL14) and Persistent Severe AKI
Keywords: CCL14; acute kidney injury; acute kidney injury and ICU nephrology; biomarker; ligands; persistent AKI.
Conflict of interest statement
J.M. Belcher reports consultancy for Chiasma Pharmaceuticals and Mallinckrodt Pharmaceuticals; honoraria from Chiasma Pharmaceuticals and Mallinckrodt Pharmaceuticals; and an advisory or leadership role for Mallinckrodt Pharmaceuticals.
Comment on
-
Performance of a Standardized Clinical Assay for Urinary C-C Motif Chemokine Ligand 14 (CCL14) for Persistent Severe Acute Kidney Injury.Kidney360. 2022 Mar 24;3(7):1158-1168. doi: 10.34067/KID.0008002021. eCollection 2022 Jul 28. Kidney360. 2022. PMID: 35919538 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
